Does Rallies show 13F holders for KAPA?

Yes. Rallies tracks hedge fund and 13F ownership data for KAPA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is KAPA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KAPA. It does not provide personalized investment advice.

KAPA (Kairos Pharma, Ltd.) Stock Analysis - Hedge Fund Holdings

Kairos Pharma, Ltd. (KAPA) is a publicly traded Healthcare sector company. As of May 21, 2026, KAPA trades at $0.49 with a market cap of $10.28M and a P/E ratio of -1.70. KAPA moved +5.13% today. Year to date, KAPA is -34.05%; over the trailing twelve months it is -13.05%. Its 52-week range spans $0.40 to $3.25. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces KAPA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns KAPA stock?

Hedge funds tracked by Rallies that own KAPA include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kairos Pharma, Ltd..

KAPA Key Metrics

Key financial metrics for KAPA
Metric	Value
Price	$0.49
Market Cap	$10.28M
P/E Ratio	-1.70
EPS	$-0.30
Dividend Yield	0.00%
52-Week High	$3.25
52-Week Low	$0.40
Volume	1.61K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-5.45M
Gross Margin	0.00%

Top Hedge Funds Holding KAPA

Citadel Advisors holds 10.97K shares of KAPA, changed +0.00% as of Dec 31, 2024.

Latest KAPA News

Kairos Pharma Signs Term Sheet to Acquire Two Clinical Oncology Assets — Feb 26, 2026

Recent KAPA Insider Trades

Murali Ramachandran bought 200 (~$318) on Nov 25, 2024.
Samuelson Doug bought 2.50K (~$3.75K) on Nov 22, 2024.
Yu John S bought 4.00K (~$5.76K) on Nov 20, 2024.

KAPA Analyst Consensus

2 analysts cover KAPA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.

Common questions about KAPA

Who owns KAPA stock?: Hedge funds tracked by Rallies that own KAPA include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kairos Pharma, Ltd..
Does Rallies show 13F holders for KAPA?: Yes. Rallies tracks hedge fund and 13F ownership data for KAPA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is KAPA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KAPA. It does not provide personalized investment advice.